American Association for Respiratory Care. AARC Guideline: infant/toddler pulmonary function tests. Respir Care1995;40(7):761–768.
2.
National asthma education program-expert panel report. Guidelines for the diagnosis and management of asthma. NIH publication 91-3042A, June1991.
3.
McNamaraRM, CionniDJ. Utility of the peak expiratory flow rate in the differentiation of acute dyspnea: cardiac vs pulmonary origin. Chest1992;101(1):129–132.
4.
CharanNB, CarvalhoP.Cardinal symptoms in respiratory disease. In: PiersonDJ, KacmarekRM, eds. Foundations of respiratory care. New York: Churchill Livingstone, 1992:199–201.
5.
TashkinDP. Dosing strategies for bronchodilator aerosol delivery. Respir Care1991;36(9):977–988.
6.
SchuhS, ParkinP, RajanA, CannyG, HealyR, RiederM, . High- versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics1989;83(4):513–518.
7.
American Association for Respiratory Care. Aerosol Consensus Statement-1991. Respir Care1991;36(9):916–921.
8.
BelliaV, ViscontiA, InsalacoG, CuttittaG, FerraraG, BonsignoreG.Validation of morning dip of peak expiratory flow as an indicator of the severity of nocturnal asthma. Chest1988;94(1):108–110.
9.
MitchellDM, GildehP, DimondAH, CollinsJV. Value of serial peak expiratory flow measurements in assessing treatment response in chronic airflow limitation. Thorax1986;41(8):606–610.
10.
ShimCS, WilliamsMHJr. Evaluation of the severity of asthma: patients versus physicians. Am J Med1980;68(1):11–13.
11.
ShimCS, WilliamsMHJr. Relationship of wheezing to the severity of obstruction in asthma. Arch Intern Med1983;132(5):890–892.
12.
LimTK, AngSM, RossingTH, IngenitoEP, IngramRH. The effects of deep inhalation on maximal expiratory flow during intensive treatment of spontaneous asthmatic episodes. Am Rev Respir Dis1989;140:340–343.
13.
LemarchandP, LabruneS, HererB, HuchonGJ. Cardiorespiratory arrest following peak expiratory flow measurement during attack of asthma. Chest1991;100(4):168–169.
14.
StanescuDC, TeculescuDB. Exercise- and cough-induced asthma. Respiration1970;27(4):377–383.
15.
SternRC, HorwitzSJ, DoershukCF. Neurologic symptoms during coughing paroxysms in cystic fibrosis. J Pediatr1988;112(6):9099–912.
16.
American Association for Respiratory Care. AARC Guideline: Spirometry. Respir Care1991;36:1414–1417.
17.
American Association for Respiratory Care. AARC Guideline: Sampling for arterial blood gas analysis. Respir Care1992;37(8):913–917.
18.
LebowitzMD. The use of peak expiratory flow rate measurements in respiratory disease. Pediatr Pulmonol1991;11:166–174.
19.
van SchayckCP, DompelingE, van WeelC, FolgeringH, van den HoogenHJ. Accuracy and reproducibility of the Assess peak flow meter. Eur Respir J1990;3(3):338–341.
20.
JonesKP, MulleeMA. Measuring peak expiratory flow in general practice: comparison of mini Wright peak flow meter and turbine spirometer. BMJ1990;300(6740):1629–1631.
21.
SimmonsM, WynegarT, HessD.Evaluation of the agreement between portable peak flow meters and a calibrated pneumotachometer. Respir Care1993;38(8):916–922.
22.
PedersenOF, MillerMR, SigsgaardT, TidleyM, HardingRM. Portable peak flow meters: physical characteristics, influence of temperature, altitude, and humidity. Eur Respir J1994;7(5):991–997.
23.
JohnsDP, AbramsonM, BowesG.Evaluation of a new ambulatory spirometer for measuring forced expiratory volume in one second and peak expiratory flow rate. Am Rev Respir Dis1992;147:1245–1250.
24.
BérubéD, CartierA, L'ArchevêqueJ, GhezzoH, MaloJ-L. Comparison of peak expiratory flow rate and FEV1 in assessing bronchomotor tone after challenges with occupational sensitizers. Chest1991;99(4):831–836.
25.
American Thoracic Society, Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. Crapo RO, chairman.Standardization of spirometry-1994 update. Am J Respir Crit Care Med1995;152:1107–1136.
26.
MahlerDA, WeinbergDH, WellsCK, FeinsteinAR. The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest1984;85(6):751–758.
27.
StollerJK, FerrantiR, FeinsteinAR. Further specification and evaluation of a new clinical index for dyspnea. Am Rev Respir Dis1986;134:1129–1134.
28.
MahlerDA, HarverA.A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis1992;145:467–470.
29.
TurnerTR, CorkeryKJ, EclemanD, GelbAM, LipavskyA, SheppardD.Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction. Chest1988;93(3):476–481.
30.
BerryRB, ShintoRA, WongFH, DespersJA, LightRW. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbation of COPD. Chest1989;96(6):1241–1246.
31.
WilkinsRL, DexterJR, SmithJR. Survey of adventitious lung sound terminology in case reports. Chest1984;85(4):523–525.
32.
BurkiNK, MitchellK, ChaudharyBA, ZechmanFW. The ability of asthmatics to detect added resistive loads. Am Rev Respir Dis1978;117:71–75.
33.
SlyPD, LandauLI, WeymouthR.Home recording of peak expiratory flow rates and perception of asthma. Am J Dis Child1985;139(5):479–482.
34.
BurdonJGW, JuniperEF, KillianKJ, HargreaveFE, CampbellEJM. The perception of breathlessness in asthma. Am Rev Respir Dis1982;126:825–828.
35.
HabibMP. Physiologic implications of artificial airways. Chest1989;96(1):180–184.
36.
ShararSR. The effects of artificial airways on airflow and ventilatory mechanics: basic concepts and clinical relevance. Respir Care1995;40(3):257–262.
37.
GottfriedSB, RossiA, HiggsBD, CalverleyPMA, ZocchiL, BozicC, Milic-EmiliJ.Noninvasive determination of respiratory system mechanics during mechanical ventilation for acute respiratory failure. Am Rev Respir Dis1985;131(3):414–420.
38.
GayPC, RodarteJR, TayyabM, HubmayrRD. Evaluation of bronchodilator responsiveness in mechanically ventilated patients. Am Rev Respir Dis1987;136(4):880–885.
39.
HessD.The delivery of aerosolized bronchodilator to mechanically ventilated intubated adult patients (editorial). Respir Care1990;35(5):399–404.
40.
KacmarekRM, HessD.The interface between patient and aerosol generator. Respir Care1991;36(9):952–976.
41.
CrinerGJ, IsaacL.Psychological issues in the ventilator-dependent patient. Respir Care1995;40(8):855–865.
42.
HetzelMR, WilliamsIP, ShakespeareRM. Can patients keep their own peak-flow records reliably?Lancet1979;1(8116):597–599.
43.
Ignacio-GarciaJM, Gonzalez-SantosP.Asthma self-management education program by home monitoring of peak expiratory flow. Am J Respir Crit Care Med1995;151:353–359.
44.
American Thoracic Society. Standardization of spirometry-1987 update. Am Rev Respir Dis1987;136:1285–1298. Printed concurrently in Respir Care 1987;32:1039–1060.
45.
EnrightPL, SherrillDL, LebowitzMD. Ambulatory monitoring of peak expiratory flow: Reproducibility and quality control. Chest1995;107:657–661.
46.
QuakenbossJJ, LebowitzMD, KrzyzanowskiM.The normal range of diurnal changes in peak expiratory flow rates: relationship to symptoms and respiratory disease. Am Rev Respir Dis1991;143:323–330.
47.
National Board for Respiratory Care. NBRC 1994 Study Guide-RRT examination. Shawnee Mission KS: National Board for Respiratory Care, 1994.
48.
National Board for Respiratory Care. NBRC 1994 Study Guide-RPFT examination. Shawnee Mission KS: National Board for Respiratory Care, 1994.
49.
National Board for Respiratory Care. NBRC 1994 Study Guide-CPFT examination. Shawnee Mission KS: National Board for Respiratory Care, 1994.
50.
National Board for Respiratory Care. NBRC 1994 Study Guide-CRTT examination. Shawnee Mission KS: National Board for Respiratory Care, 1994.
51.
Centers for Disease Control. Update: Universal Precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR1988;37:377–382,387–388.
52.
Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related tissues. MMWR1990;39(RR-17):1–29.
53.
GravelynTR, WegJG. Respiratory rate as an indicator of acute respiratory dysfunction. JAMA1980;244(10):1123–1125.
54.
McFaddenJP, PriceRC, EastwoodHD, BriggsRS. Raised respiratory rate in elderly patients: a valuable physical sign. BMJ1982;284(6316):626–627.
55.
BrowningIB, D'AlonzoGE, TobinMJ. Importance of respiratory rate as an indicator of respiratory dysfunction in patients with cystic fibrosis. Chest1990;97(6):1317–1321.
56.
NewhouseMT, DolovichMB. Aerosol therapy of reversible airflow obstruction-concepts and clinical applications. Chest1987;91(5, suppl):58–64.
57.
ToogoodJH. Helping your patients make better use of MDIs and spacers. J Respir Dis1994;15:2,151–164.
58.
MeltzerAA, SmolenskyMH, D'AlonzoGE, HarrisRB, ScottPH. An assessment of peak expiratory flow as a surrogate measurement of FEV1 in stable asthmatic children. Chest1989;96(2):329–333.
59.
MestitzH, CoplandJM, McDonaldCF. Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic air flow obstruction. Chest1989;96(6):1237–1240.
60.
CissikJH, BodeFR, SmithJA. Double-blind crossover study of five bronchodilator medications and two delivery methods in stable asthma: is there a best combination for use in the pulmonary laboratory?Chest1986;90:(4):489–493.
61.
ShimCS, WilliamsMHJr. Effect of bronchodilator therapy administered by canister versus jet nebulizer. J Allerg Clin Immunol1984;73(3):387–390.
62.
American Thoracic Society. Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis1991;144(5):1202–1218.
63.
JenkinsSC, HeatonRW, FultonTJ, MoxhamJ.Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest1987;91(6):804–807.
64.
FernandezA, LazaroA, GarciaA, AeagonC, CerdaE.Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation: utilization of metered-dose inhalers. Am Rev Respir Dis1990;141:164–168.
65.
ReddelHK, SalomeCM, PeatJK, WoolcockAJ. Which index of peak expiratory flow is most useful in the management of stable asthma?Am J Respir Crit Care Med1995;151:1320–1325.
66.
HarmDL, KotsesH, CreerTL. Improving the ability of peak expiratory flow rates to predict asthma. J Allergy Clin Immunol1985;76(5):688–694.
67.
AhmedJ, BrutusA, D'AmatoRF, GlattAE. Acinetobacter calcoaceticus anitratus outbreak in the intensive care unit traced to a peakflow meter. Am J Infect Control1994;22(5):319–321.
68.
AdelrothE, HargreaveFE, RamsdaleEH. Do physicians need objective measurements to diagnose asthma?Am Rev Respir Dis1986;134(4):704–707.
BolderPM, HealyTE, BolderAR, BeattyPC, KayB.The extra work of breathing through adult endotracheal tubes. Anesth Analg1986;65(8):853–859.
71.
BaM, SpierS, LapierreG, LamarreA.Wet nebulizer versus spacer and metered dose inhaler via tidal breathing. J Asthma1989;26(6):355–358.
72.
BerstenAD, RuttenAJ, VedigAE, SkrowronskiGA. Additional work of breathing imposed by endotracheal tubes, breathing circuits, and intensive care ventilators. Crit Care Med1989;17(7):671–677.
73.
ClarkNM, EvansMelllins RB. Patient use of peak flow monitoring. Am Rev Respir Dis1992;145:722–725.
74.
ComstockGW, TockmanMS, HesingKJ, HennesyKM. Standardized respiratory questionnaires: comparison of the old with the new. Am Rev Respir Dis1979;119(1):45–53.
75.
CookNR, EvansDA, ScherrPA, SpeizerFE, VedalS, BranchLG, . Peak expiratory flow rate in an elderly population. Am J Epidemiol1989;130(1):66–78.
76.
EichenhomMS, BeauchampRK, HarperPA, WardJC. An assessment of three portable peak flow meters. Chest1982;82(3):306–309.
77.
FernandezR, SoleJ, BlanchL, ArtigasA.The effect of short-term instillation of a mucolytic agent (Mesna) on airway resistance in mechanically ventilated patients. Chest1995;107(4):1101–1106.
78.
GalTJ, SurattPM. Resistance to breathing in healthy subjects following endotracheal intubation under topical anesthesia. Anesth Analg1980;59(4):270–274.
79.
GautrinD, D'AquinoLC, GagnonG, MaloJ-L, CartierA.Comparison between peak expiratory flow rates (PEFR) and FEV1 in the monitoring of asthmatic subjects at an outpatient clinic. Chest1994;106(5):1419–1426.
80.
GayPC, PatelHG, NelsonSB, GillesB, HubmayrRD. Metered dose inhalers for bronchodilator delivery in intubated mechanically ventilated patients. Chest1991;99(1):66–71.
GodfreyS, KonigP.Suppression of exercise-induced asthma by salbutamol, theophylline, atropine, cromolyn, and placebo in a group of asthmatic children. Pediatrics1975;56(5, Part 2, suppl):930–934.
83.
GodfreyS.Exercise-induced asthma-clinical physiological, and therapeutic implications. J Allergy Clin Immunol1975;56(1):1–17.
84.
GuptaCK, MathurN.Statistical models relating peak expiratory flow rates to age, height, and weight in men and women. J Epidemiol Community Health1982;36(1):64–67.
85.
HarmDL, MarionRJ, CreerTL, KotsesH.Effects of instructions on pulmonary function values. J Asthma1985;22(6):289–294.
86.
KellyCA, GibsonGJ. Relation between FEV1 and peak expiratory flow in patients with chronic airflow obstruction. Thorax1988;43(4):335–336.
87.
LevinsonH, ReillyPA, WorsleyGH. Spacing devices and metered-dose inhalers in childhood asthma. J Pediatr1985;107(5):662–668.
MorganMDL, SinghBV, FrameMH, WilliamsSJ. Terbutaline aerosol given through pear spacer in acute severe asthma. BMJ1985;285(6345):849–850.
92.
O'CallaghanC, MilnerAD, SwarbrickA.Spacer device with face mask attachment for giving bronchodilators to infants with asthma. BMJ1989;298(6667):160–161.
93.
O'ReillyJF, GouldG, KendrickAH, LaszloG.Domiciliary comparison of terbutaline treatment by metered dose inhaler with and without conical spacer in severe and moderately severe chronic asthma. Thorax1986;41(10):766–770.
94.
PollackCVJr. Utilization of the peak expiratory flow rate in evaluation of acute dyspnea of cardiac or pulmonary origin (letter). Chest1993;103(4):1306–1307.
95.
RamsdaleEH, MorrisMM, HargreaveFE. Interpretation of peak flow rates in chronic bronchitis. Thorax1986;41(10):771–776.
96.
ShapiroM, WilsonRK, CasarG, BloomK, TeagueRB. Work of breathing through different sized endotracheal tubes. Crit Care Med1986;14(12):1028–1031.
97.
ThomasP, PugsleyJA, StewartJH. Theophylline and salbutamol improve pulmonary function in patients with chronic obstructive pulmonary disease. Chest1992;101(1):160–165.
98.
VenablesKM, BurgesPS, DavisonAG, Newman-TaylorAJ. Peak flow rate records in surveys: reproducibility of observers' reports. Thorax1984;39(11):828–832.
WeissmanC, AskanaziJ, RosenbaumSH, DamaskMC, HyanAl, KinneyJM. Response to tubular airway resistance in normal subjects and postoperative patients. Anesthesiology1986;64(3):353–358.
101.
WrightPE, MariniJJ, BernardGR. In vitro versus in vivo comparison of endotracheal tube airflow resistance. Am Rev Respir Dis1989;140(1):10–16.
ZandstraDF, StoutenbeekCP, MirandaDR. Effect of mucolytic and bronchodilator aerosol therapy on airway resistance in mechanically ventilated patients. Intensive Care Med1985;11(6):316–318.
104.
ZureikM, LiardR, SegalaC, HenryC, KorobaeffM, NeukirchF.Peak expiratory flow rate variability in population surveys: does the number of assessments matter. Chest1995;107:418–423.